Biomarkers (4)
- Calculated_LDL-C - Blood lipid level - LDL-C (phv00283872.v1.p1)
- HDL-C - Blood lipid level - HDL-C (phv00283870.v1.p1)
- Total_cholesterol - Blood lipid level - TC (phv00283869.v1.p1)
- Triglycerides - Blood lipid level - TG (phv00283871.v1.p1)
Demographics (3)
- age_at_sampling - Subject's age at sampling (phv00283868.v1.p1)
- sex - Gender of participant (phv00283866.v1.p1)
- SEX - Sex (phv00328803.v1.p1)
Race and Ethnicity (1)
- self-reported_ethnicity - Self-reported ethnicity of participant (phv00283867.v1.p1)
Other (20)
- affection_status - Case control status of the subject for cardiovascular disease or lipoprotein metabolism disorders (phv00283861.v1.p1)
- analyte_type - Analyte Type (phv00313419.v1.p1)
- body_site - Body site where sample was collected (phv00313418.v1.p1)
- consent - Consent group as determined by DAC (phv00283860.v1.p1)
- FACS_Tra-1-60_and_SSEA-4_positive - FACS staining for differentiation assessment (phv00283873.v1.p1)
- FAMILY_ID - Family ID (phv00328799.v1.p1)
- FATHER - Father's Subject ID (phv00328801.v1.p1)
- genotyping_center - Name of the center which conducted genotyping (phv00313422.v1.p1)
- histological_type - Cell or tissue type or subtype of sample (phv00313420.v1.p1)
- is_tumor - Tumor status (phv00313421.v1.p1)
- MOTHER - Mother's Subject ID (phv00328802.v1.p1)
- SAMPLE_ID - Sample ID for each cell type (phv00313417.v1.p1)
- SAMPLE_ID - Sample ID (phv00283863.v1.p1)
- SAMPLE_USE - Sample Use (phv00283864.v1.p1)
- sequencing_center - Name of the center which conducted sequencing (phv00313423.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00283865.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00313416.v1.p1)
- SUBJECT_ID - Unique Subject ID (phv00328800.v1.p1)
- SUBJECT_ID - Subject ID (phv00283859.v1.p1)
- SUBJECT_ID - Subject ID (phv00283862.v1.p1)